Table 3.
Kaplan Meier results for the entire cohort, and for the moderate- and high-vascular groups, generated by the combined cut off threshold (9.8), when comparing the populations with methylated and unmethylated MGMT.
| Survival Rates According to MGMT Methylation and Tumor Vascularity | Number of Patients | KM Results | |||||
|---|---|---|---|---|---|---|---|
| Kaplan-Meier Analysis | Total | Meth. MGMT |
Unmeth. MGMT |
Median OS Meth. MGMT | Median os Unmeth. Mgmt |
|ΔOS| | p-Value |
| Entire cohort | 123 | 67 | 56 | 578 | 462 | 114 | 0.0220 * |
| Moderate rCBV | 71 | 46 | 34 | 641 | 467 | 174 | 0.0129 * |
| High rCBV | 53 | 21 | 22 | 454 | 461 | 7 | 0.9119 |
* Significant p-values: < 0.05. Meth. MGMT: methylated MGMT; Unmeth. MGMT: unmethylated MGMT; OS: overall survival.